Showing results (1201-1210 of 1,527) with videos related to
Sort By:
Pageof 153
Urologic Oncology|August 2, 2015
Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial designWillemien van den Bos, Berrend G Muller, Daniel M de Bruin, et al.JCI Insight|August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinomaNicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.Epilepsia|December 10, 2016
Interictal epileptiform discharges impair word recall in multiple brain areasPeter C Horak, Stephen Meisenhelter, Yinchen Song, et al.Urologic Oncology|November 28, 2022
A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomyEvan E Gross, Mingjia Li, Ming Yin, et al.Cancer Immunology Research|June 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumorsHoward L Li, Soren Charmsaz, Chester Kao, et al.Neurology|February 10, 2015
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsyVicenta Salanova, Thomas Witt, Robert Worth, et al.Brain Stimulation|November 13, 2025
Non-invasive temporal interference stimulation of the hippocampus suppresses epileptic biomarkers in patients with Epilepsy: biophysical differences between kilohertz and amplitude modulated stimulationFlorian Missey, Emma Acerbo, Adam S Dickey, et al.Orthopaedic Journal of Sports Medicine|July 12, 2021
Metrics of OsteoChondral Allografts (MOCA) Group Consensus Statements on the Use of Viable Osteochondral AllograftSimon Görtz, Suzanne M Tabbaa, Deryk G Jones, et al.Journal for Immunotherapy of Cancer|April 21, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinomaHoward L Li, Soren Charmsaz, Benjamin J Reisman, et al.Forensic Science International. Genetics|March 14, 2023
Development and evaluations of the ancestry informative markers of the VISAGE Enhanced Tool for Appearance and AncestryJ Ruiz-Ramírez, M de la Puente, C Xavier, et al.Pageof 153